In the small-cap biotech space, the biggest opportunities often come from companies working on breakthrough therapies in ...

In this article, we will look at the 10 Best Small Cap Biotech Stocks to Buy According to Hedge Funds. On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer ...

Following a turbulent year for the markets in general and biotech in particular, the industry made a notable recovery, ...

With the notable exceptions of Novo Nordisk A/S (NYSE: NVO) and Eli Lilly & Co. (NYSE: LLY), biotechnology stocks had a rough time attracting investment capital in 2024. Small- and mid-cap biotech ...

Both Iovance Biotherapeutics IOVA and Rigel Pharmaceuticals RIGL are small-cap companies focused on the successful commercialization of their marketed products. While Iovance is a cancer biotech ...

The green shoots suggesting a comeback was in sight for biotech stocks last year have mostly grown into proverbial flowering plants—but one company’s precipitous year-over-year decline in market ...

ORLANDO, FL / ACCESS Newswire / April 2, 2026 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced its upcoming ...

If you buy market folklore about January being an indicator for the rest of the year, the start of 2026 bodes well for small-cap stocks. The table is set for a "positive surprise" in small caps, ...

Small caps have started holding up better than many large-cap benchmarks, but this is not a blind rush into everything below the mega-cap tier. The better angle is selective market broadening: ...

After several years of persistent headwinds, small-cap equities may finally be entering a more supportive phase. Lower interest rates matter disproportionately for small-cap businesses. Compared with ...